Product Information

FLUTICASONE-SALMETEROL 250-50 is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.2785 per EA under NDC 00054032756. Its NADAC has been published 275 times since May 19, 2021.

FDA first approved this application on Dec 17, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FLUTICASONE-SALMETEROL 250-50

fluticasone propionate and salmeterol
$1.2785per EA

Strength

250; 50 ug/1; ug/1

NDC

00054032756

Classification

Generic

Dosage Form

POWDER

Route

RESPIRATORY (INHALATION)

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA203433

FDA Approved

12/17/2020

TE Code

AB

On Market Since

12/17/2020

Pharmacological Classes

Adrenergic beta2-Agonists
Corticosteroid Hormone Receptor Agonists
Corticosteroid
beta2-Adrenergic Agonist

Price Statistics

The NADAC for FLUTICASONE-SALMETEROL 250-50 has been published 275 times since May 19, 2021, and over the history we have for it it has declined 50.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2785 per EA
All-time high$2.6054 (Jun 16, 2021)
All-time low$1.0972 (Apr 17, 2024)
52-week high$1.3802
52-week low$1.2785
Median price$1.5190
Average price$1.6148
Largest weekly change-30.5% (Apr 17, 2024)
Weeks tracked275
Tracking sinceMay 19, 2021

Price History

1W

-1.9%

1M

-1.9%

3M

-3.7%

6M

-3.7%

1Y

-7.4%

3Y

-21.4%

5Y

-45.6%

All

-50.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FLUTICASONE-SALMETEROL 250-50?

The current National Average Drug Acquisition Cost (NADAC) for FLUTICASONE-SALMETEROL 250-50, manufactured by Hikma Pharmaceuticals USA Inc., is $1.2785 per EA (NDC 00054032756), effective Aug 19, 2026.

How has the price of FLUTICASONE-SALMETEROL 250-50 changed over time?

Over the history we have for it, the NADAC for FLUTICASONE-SALMETEROL 250-50 has declined 50.9%. It has been tracked across 275 weekly CMS publications since May 19, 2021.

What are the highest and lowest recorded NADAC prices for FLUTICASONE-SALMETEROL 250-50?

Since May 19, 2021, the NADAC for FLUTICASONE-SALMETEROL 250-50 has ranged from a low of $1.0972 (Apr 17, 2024) to a high of $2.6054 (Jun 16, 2021), with a median of $1.5190 per EA.

Are there cheaper alternatives to FLUTICASONE-SALMETEROL 250-50?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUTICASONE-SALMETEROL 250-50 in a comparable dosage form, but none are currently priced below it.

Who manufactures FLUTICASONE-SALMETEROL 250-50?

FLUTICASONE-SALMETEROL 250-50 (NDC 00054032756) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.